Wissenschaftliche Arbeiten

Prof. Dr. Levent Türkeri

208 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Vascular Endothelial Growth Factor and Thrombospondin-1 mRNA Expression in Bladder Tumors: Correlation with Histopathology and Prognosis

    Bulletin of Urooncology, 2019

    DOI 10.4274/uob.galenos.2018.1179 Quelle: OpenAlex

  2. Normotensive, Oversized Pheochromocytoma in Twin-Pregnancy: Analysis of Therapeutic Challenges in a Rare Case

    Case Reports in Urology, 2019

    DOI 10.1155/2019/7141060 PMID 31249716 Frei zugänglicher VolltextQuelle: OpenAlex

  3. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms

    Clinical Laboratory, 2019

    DOI 10.7754/clin.lab.2018.180339 PMID 30969078 6 Zitationen (Europe PMC) Quelle: OpenAlex

  4. Management of patients with advanced prostate cancer in the Asia Pacific region: ‘real‐world’ consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017

    British Journal of Urology, 2018

    DOI 10.1111/bju.14489 PMID 30019467 31 Zitationen (Europe PMC) Quelle: OpenAlex

  5. Report of the third Asian Prostate Cancer study meeting

    Prostate International, 2018

    DOI 10.1016/j.prnil.2018.06.001 PMID 31384607 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy: Results from a Contemporary Turkish Patient Cohort

    Urologia Internationalis, 2017

    DOI 10.1159/000481266 PMID 29275406 3 Zitationen (Europe PMC) Quelle: OpenAlex

  7. Initial Outcomes and Assessment of the Transperineal Multiparametric-Magnetic Resonance Imaging/Ultrasonography Fusion Biopsy Method in Diagnosing Clinically-significant Prostate Cancer

    Bulletin of Urooncology, 2017

    DOI 10.4274/uob.805 Quelle: OpenAlex

  8. Stem cell therapies in post-prostatectomy erectile dysfunction: a critical review.

    PubMed, 2017

    PMID 28263125 24 Zitationen (Europe PMC) Quelle: OpenAlex

  9. Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting

    Prostate International, 2017

    DOI 10.1016/j.prnil.2017.03.006 PMID 28828352 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Design and Validation of the Marmara Post-prostatectomy Incontinence Symptom Score

    Journal of Urological Surgery, 2017

    DOI 10.4274/jus.1097 Quelle: OpenAlex

  11. An Independent Validation of 2010 Tumor-Node-Metastasis Classification for Renal Cell Carcinoma: A Multi-center Study by the Urooncology Association of Turkey Renal Cancer-Study Group

    Journal of Urological Surgery, 2017

    DOI 10.4274/jus.1369 Frei zugänglicher VolltextQuelle: OpenAlex

  12. Clinical Case Discussion: Bilateral Synchronous Testicular Cancer and Organ-sparing Surgery

    European Urology Focus, 2016

    DOI 10.1016/j.euf.2016.08.003 PMID 28753784 4 Zitationen (Europe PMC) Quelle: OpenAlex

  13. Investigation of the association between mitochondrial DNA and p53 gene mutations in transitional cell carcinoma of the bladder

    Oncology Letters, 2016

    DOI 10.3892/ol.2016.5000 PMID 27698873 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  14. Super-Sele. Embolization of Vesical Arteries with Micro-Catheter Technique in the Treatment of Intractable Hemorrhage due to Bladder Cancer

    Bulletin of Urooncology, 2016

    DOI 10.4274/uob.448 Quelle: OpenAlex

  15. Association of missense substitution of A49T and V89L in the SRD5A2 gene with prostate cancer in Turkish patients

    Turkish Journal of Biochemistry, 2016

    DOI 10.1515/tjb-2016-0164 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. Should We Perform Thoracic Imaging for Every Patient with a Renal Mass?

    Bulletin of Urooncology, 2016

    DOI 10.4274/uob.678 Quelle: OpenAlex

  17. Abdominal or Transrectal Ultrasonographic Prostate Volume and Cystoscopic Prostatic Urethral Length Measurements to Determine the Surgical Technique for Prostatectomy in Patients with Benign Prostate Hyperplasia

    Journal of Urological Surgery, 2016

    DOI 10.4274/jus.954 Quelle: OpenAlex

  18. MDT in uro-oncology: Difficult cases in high risk urothelial cancer

    European Urology Supplements, 2016

    DOI 10.1016/s1569-9056(16)30034-3 Quelle: OpenAlex

  19. A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”

    Bulletin of Urooncology, 2016

    DOI 10.4274/uob.434 Quelle: OpenAlex

  20. Effect of Age on Outcome of High-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated with Second Transurethral Resection and Maintenance Bacillus Calmette-Guerin Therapy

    Journal of Urological Surgery, 2016

    DOI 10.4274/jus.2016.1009 Frei zugänglicher VolltextQuelle: OpenAlex

  21. MP42-20 PATHOLOGIC OUTCOMES OF CANDIDATES FOR ACTIVE SURVEILLANCE UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM A CONTEMPORARY TURKISH PATIENT COHORT

    The Journal of Urology, 2015

    DOI 10.1016/j.juro.2015.02.1605 Quelle: OpenAlex

  22. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

    European Urology, 2015

    DOI 10.1016/j.eururo.2015.06.045 PMID 26210894 518 Zitationen (Europe PMC) Quelle: OpenAlex

  23. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high‐risk non‐muscle‐invasive bladder cancer treated with maintenance intravesical Bacillus Calmette‐Guérin

    British Journal of Urology, 2015

    DOI 10.1111/bju.13102 PMID 25715815 34 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  24. Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?

    Korean journal of urology, 2015

    DOI 10.4111/kju.2015.56.5.357 PMID 25964836 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  25. Effects of testosterone treatment on recovery of rat spermatogenesis after irradiation.

    PubMed, 2015

    PMID 25933566 1 Zitation (Europe PMC) Quelle: OpenAlex

  26. Can We Predict the Surgical Margin Positivity in Patients Treated with Radical Prostatectomy? A Multicenter Cohort of Turkish Association of Uro-Oncology

    Journal of Urological Surgery, 2015

    DOI 10.4274/jus.220 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Radical Prostatectomy is a Valuable Treatment Alternative in Patients with High-Risk Prostate Cancer

    Journal of Urological Surgery, 2015

    DOI 10.4274/jus.216 Quelle: OpenAlex

  28. Mesenchymal stem cell therapy in treatment of erectile dysfunction: Autologous or allogeneic cell sources?

    International Journal of Urology, 2014

    DOI 10.1111/iju.12585 PMID 25074479 22 Zitationen (Europe PMC) Quelle: OpenAlex

  29. Outcomes of Fecal Carriage of Extended-spectrum β-Lactamase After Transrectal Ultrasound–guided Biopsy of the Prostate

    Urology, 2014

    DOI 10.1016/j.urology.2014.04.060 PMID 25239255 19 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Identification of Patients with Microscopic Hematuria who are at Greater Risk for the Presence of Bladder Tumors Using a Dedicated Questionnaire and Point of Care Urine Test - A Study by the Members of Association of Urooncology, Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.15.6283 PMID 25124612 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  31. The course of metastatic prostate cancer under treatment

    SpringerPlus, 2014

    DOI 10.1186/2193-1801-3-725 PMID 25674461 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  32. Quimioterapia basada en docetaxel en el tratamiento de pacientes con cáncer de prostata resistente a la castración

    Actas Urológicas Españolas, 2014

    DOI 10.1016/j.acuro.2013.12.012 PMID 24646918 1 Zitation (Europe PMC) Quelle: OpenAlex

  33. Docetaxel based chemotherapy in the treatment of patients with castration resistant prostate cancer

    Actas Urológicas Españolas (English Edition), 2014

    DOI 10.1016/j.acuroe.2014.06.008 Quelle: OpenAlex

  34. S091: Superselective embolization of the vesical artery for the control of intractable hematuria secondary to bladder cancer

    European Urology Supplements, 2014

    DOI 10.1016/s1569-9056(14)61673-0 Quelle: OpenAlex

  35. Is there a relationship between the number of lymph nodes and disease parameters in patients who underwent retropubic prostatectomy

    International Urology and Nephrology, 2014

    DOI 10.1007/s11255-014-0692-3 PMID 24664551 Quelle: OpenAlex

  36. Anxiety and Depression are Two Important Causes of Erectile Dysfunction after Saturation Biopsy: A Pilot Study

    Journal of Urological Surgery, 2014

    DOI 10.4274/jus.94 Quelle: OpenAlex

  37. Bacillus Calmette Guérin Yokluğunda Yüksek Riskli Mesane Kanserine Yaklaşım: Tedavi Seçenekleri ve Takip Protokolümüz Nasıl Olmalı?

    Bulletin of Urooncology, 2014

    DOI 10.4274/uob.09 Quelle: OpenAlex

  38. Reply

    Urology, 2014

    DOI 10.1016/j.urology.2014.04.063 PMID 25239256 Quelle: OpenAlex

  39. Massive rectal bleeding after prostate biopsy controlled by endoclipping in a patient using ASA

    Canadian Urological Association Journal, 2013

    DOI 10.5489/cuaj.1390 PMID 23826061 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG

    European Urology, 2013

    DOI 10.1016/j.eururo.2013.07.021 PMID 23910233 270 Zitationen (Europe PMC) Quelle: OpenAlex

  41. Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

    Clinical & Translational Oncology, 2013

    DOI 10.1007/s12094-013-1047-8 PMID 23615982 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  42. Preliminary Results of Noninvasive Detection ofTMPRSS2:ERGGene Fusion in a Cohort of Patients With Localized Prostate Cancer

    Korean journal of urology, 2013

    DOI 10.4111/kju.2013.54.6.359 PMID 23789042 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  43. An Alternative for Short Renal Vein During Kidney Transplantation: Long-term Experience With Polyethylene Terephthalate (Dacron) Vascular Graft

    Urology, 2013

    DOI 10.1016/j.urology.2013.02.031 PMID 23541223 5 Zitationen (Europe PMC) Quelle: OpenAlex

  44. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.

    PubMed, 2013

    PMID 24231293 Quelle: OpenAlex

  45. Impact Of Fecal Carriage Of Extended Spectrum Beta-lactamase Producing Enterobacteriaceae(esbl-pe) Before Transrectal Needle Biopsy Of The Prostate

    Marmara medical journal, 2013

    DOI 10.5472/mmj.2013.02786.2 Frei zugänglicher VolltextQuelle: OpenAlex

  46. DESIGN AND VALIDATION OF MARMARA POST-PROSTATECTOMY INCONTINENCE SYMPTOM SCORE (M-PPISS)

    ics.org, 2013

    Quelle: OpenAlex

  47. NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG

    Dspace Repository (Marmara Üniversitesi), 2013

    Quelle: OpenAlex

  48. Simultaneous robot-assisted radical cystoprostatectomy and nephroureterectomy in a patient with multifocal invasive urothelial carcinoma and previous contralateral nephroureterectomy

    Journal of Robotic Surgery, 2012

    DOI 10.1007/s11701-012-0381-0 PMID 27001880 1 Zitation (Europe PMC) Quelle: OpenAlex

  49. Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

    European Urology, 2012

    DOI 10.1016/j.eururo.2012.10.039 PMID 23141049 366 Zitationen (Europe PMC) Quelle: OpenAlex

  50. Detection of Mitochondrial DNA Mutations in Nonmuscle Invasive Bladder Cancer

    Genetic Testing and Molecular Biomarkers, 2012

    DOI 10.1089/gtmb.2011.0227 PMID 22533676 19 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex